Skip to content
★ Sign in to follow
LH

Lars Holmqvist

EQL Pharma
Total declarations
7
Company
1
▲ Purchases (1 ops.)
—
▼ Sales (2 ops.)
€0

Latest filing published 15 Nov 2018 for EQL Pharma.

Filing timeline

BuySale
Lars Holmqvist

Insider track record

Disclosed buys
1
Disclosed sells
2
Signal history

No signal scores available.

Closed purchases

Market purchases
1

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Lars Holmqvist: trading record in brief

All filings by Lars Holmqvist on record concern EQL Pharma. We count 7 filings; the first trade dates from 7 November 2018 and the latest from 13 November 2018.

Market trades split into 1 purchase and 2 sales (€0). The totals exclude 2 filings filed without an amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price.

The record was last updated on 15 November 2018 with an open-market sale in EQL Pharma. The last insider purchase was made public on 15 November 2018, 2,914 days ago. The median gap between a trade and its publication by Finansinspektionen is 2 days. The regulation allows three business days to notify a trade (MAR article 19). Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.

Companies and markets linked to Lars Holmqvist

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations7 total
  • ▼
    Styrelseledamot/suppleantExecutivesEQL Pharma
    0FI-SE
    243,232 shares0TeckningsrättISIN SE0011844166FI:csv-eb4b77b871ba65e038a9
  • ▲
    Styrelseledamot/suppleantExecutivesEQL Pharma
    0FI-SE
    243,232 shares0TeckningsrättISIN SE0011844166FI:csv-92768fb52da43a2e9116
    Canonical exit: 5 Feb 2019 (T+90)
  • ●
    Styrelseledamot/suppleantExecutivesEQL Pharma
    243,228 SEK0FI-SE
    40,538 shares@ SEK 6.0049.9% of flowTeckningsrättISIN SE0011844174FI:csv-4c7d8eafc0b69b85e40b
  • ▼
    Styrelseledamot/suppleantExecutivesEQL Pharma
    2 SEK0FI-SE
    4 shares@ SEK 0.450.0% of flowTeckningsrättISIN SE0011844166FI:csv-41e0ffdc2bb1d2fa8ed1
  • ●
    Styrelseledamot/suppleantExecutivesEQL Pharma
    0FI-SE
    243,232 shares0TeckningsrättISIN SE0011844166FI:csv-c0f595c70d16cce1da4b
  • ●
    Styrelseledamot/suppleantExecutivesEQL Pharma
    244,200 SEK12FI-SE
    40,700 shares@ SEK 6.0050.1% of flowAktieISIN SE0011844174FI:csv-ae011f087e30c868b1f6
  • ●
    Styrelseledamot/suppleantExecutivesEQL Pharma
    0FI-SE
    244,200 shares0TeckningsrättISIN SE0011844166FI:csv-3dbca055e29daaee630b

7 of 7 declarations